ALPL
alkaline phosphatase, liver/bone/kidney
ALPL; alkaline phosphatase, liver/bone/kidney; HOPS; alkaline phosphatase, tissue-nonspecific isozyme; TNSALP; glycerophosphatase; tissue-nonspecific ALP; alkaline phosphomonoesterase; liver/bone/kidney-type alkaline phosphatase; alkaline phosphatase live;
Blvra
biliverdin reductase A
BLVRA; biliverdin reductase A; BLVR; Biliverdin IX alpha reductase; BLVR A; BVR A; BVR; BVRA; Zinc metalloprotein; OTTHUMP00000159196; OTTHUMP00000207534; biliverdin-IX alpha-reductase;
BLVRB
biliverdin reductase B (flavin reductase (NADPH))
BLVRB; biliverdin reductase B (flavin reductase (NADPH)); Flavin reductase , FLR; flavin reductase (NADPH); SDR43U1; short chain dehydrogenase/reductase family 43U; member 1; Biliverdin IX beta reductase; Biliverdin reductase B; Biliverdin-IX beta-reductase; BLVRB_HUMAN; BVR B; BVR-B; BVRB; Flavin reductase; FLR; FR; GHBP; Green heme binding protein; Green heme-binding protein; MGC117413; NADPH dependent diaphorase; NADPH flavin reductase; NADPH-dependent diaphorase; NADPH-flavin reductase; short chain dehydrogenase/reductase family 43U, member 1;
FABP1
fatty acid binding protein 1, liver
FABP1; fatty acid binding protein 1, liver; FABPL; L-FABP; fatty acid-binding protein, liver; fatty acid-binding protein 1; liver-type fatty acid-binding protein;
PKLR
pyruvate kinase, liver and RBC
PKLR; pyruvate kinase, liver and RBC; pyruvate kinase isozymes R/L; pyruvate kinase 1; pyruvate kinase type L; pyruvate kinase isozyme R/L; R-type/L-type pyruvate kinase; red cell/liver pyruvate kinase; pyruvate kinase, liver and blood cell; PK1; PKL; PKR;
CDH17
cadherin 17, LI cadherin (liver-intestine)
CDH17; cadherin 17, LI cadherin (liver-intestine); cadherin-17; cadherin; HPT 1; LI cadherin; LI-cadherin; cadherin-16; HPT-1 cadherin; liver-intestine cadherin; human peptide transporter 1; intestinal peptide-associated transporter HPT-1; human intestina;
CPT1A
carnitine palmitoyltransferase 1A (liver)
CPT1A; carnitine palmitoyltransferase 1A (liver); CPT1; carnitine O-palmitoyltransferase 1, liver isoform; CPT1 L; L CPT1; CPT I; CPTI-L; carnitine palmitoyltransferase I, liver; carnitine O-palmitoyltransferase I, liver isoform; CPT1-L; L-CPT1;
GYS2
glycogen synthase 2 (liver)
GYS2; glycogen synthase 2 (liver); glycogen [starch] synthase, liver; Glycogen starch synthase liver; EC 2.4.1.11; Glycogen synthase 2 liver;
PFKL
phosphofructokinase, liver
PFKL; phosphofructokinase, liver; 6-phosphofructokinase, liver type; phosphohexokinase; phosphofructokinase 1; liver-type 1-phosphofructokinase; phosphofructo-1-kinase isozyme B; PFK-B; FLJ30173; FLJ40909; DKFZp686G1648; DKFZp686L2097;
PHKA2
phosphorylase kinase, alpha 2 (liver)
PHKA2; phosphorylase kinase, alpha 2 (liver); PHK, PYK; phosphorylase b kinase regulatory subunit alpha, liver isoform; phosphorylase kinase alpha-subunit; phosphorylase kinase alpha L subunit; phosphorylase b kinase regulatory subunit alpha liver isoform;
GFER
growth factor, augmenter of liver regeneration
GFER; growth factor, augmenter of liver regeneration; ALR; HPO; HSS; ERV1; HPO1; HPO2; HERV1; FAD-linked sulfhydryl oxidase ALR; ERV1 homolog; hepatopoietin protein; erv1-like growth factor; hepatic regenerative stimulation substance;
PYGL
phosphorylase, glycogen, liver
PYGL; phosphorylase, glycogen, liver; phosphorylase, glycogen; liver; glycogen phosphorylase, liver form; glycogen storage disease type VI; Hers disease; GSD6;
DLC1
deleted in liver cancer 1
DLC1; deleted in liver cancer 1; rho GTPase-activating protein 7; ARHGAP7; DLC 1; HP; p122 RhoGAP; StAR related lipid transfer (START) domain containing 12; STARD12; Rho-GTPase-activating protein 7; deleted in liver cancer 1 protein; START domain-containing protein 12; deleted in liver cancer 1 variant 2; rho-type GTPase-activating protein 7; StAR-related lipid transfer (START) domain containing 12; p122-RhoGAP; FLJ21120;
RNASE2
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
RNASE2; ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin); RNS2; non-secretory ribonuclease; EDN; Ear4; EC=3.1.27.5; Eosinophil cationic type ribonuclease 4; MR 4; Non secretory ribonuclease; R14; R15; R5; Ribonuclease 2; Ribonuclease RNase A family 2 (liver eosinophil derived neurotoxin); Ribonuclease US; RNase 2; RNase UpI 2; RNase UpI-2; eosinophil-derived neurotoxin;
GLS2
glutaminase 2 (liver, mitochondrial)
GLS2; glutaminase 2 (liver, mitochondrial); glutaminase liver isoform, mitochondrial; GA; GLS; hLGA; LGA; L-glutaminase; glutaminase I; glutaminase GA; breast cell glutaminase; L-glutamine amidohydrolase; phosphate-activated glutaminase; phosphate-depende;
LEAP2
liver expressed antimicrobial peptide 2
LEAP2;liver expressed antimicrobial peptide 2;29571;ENSG00000164406;LEAP-2;5q31.1;liver-expressed antimicrobial peptide 2;liver-expressed antimicrobial peptide 2;
Cox7a2
COX7A2 cytochrome c oxidase subunit VIIa polypeptide 2 (liver) [ Homo sapiens ]
COX7A2; COX7AL; COX7AL1; COXVIIa L; COXVIIAL; CX7A2_HUMAN; Cytochrome c oxidase polypeptide 7A2 mitochondrial; Cytochrome c oxidase polypeptide VIIa liver/heart; Cytochrome c oxidase subunit 7A2; Cytochrome c oxidase subunit 7A2 mitochondrial; Cytochrome c oxidase subunit VIIa polypeptide 2; Cytochrome c oxidase subunit VIIa-L; Cytochrome c oxidase subunit VIIa-liver/heart; Cytochrome c oxidase subunit VIIaL; Hepatic cytochrome c oxidase chain VIIa; MGC118950; MGC118951; MGC118952; MGC126875; MGC126877; mitochondrial; VIIAL;
Inhibition of Enzyme NOX4 Prevents Liver Fibrosis than TGF-beta
Liver fibrosis is an illness caused by the overproduction of extracellular matrix proteins in the liver tissue. NOX4, a family member of NADPH oxidase enzyme,plays an important role in liver fibrosis by inhibiting it. TGF-beta, a complex cytokine, the transforming growth factor-beta, involves in the...
